Top Biotechnology & Medical Research stocks in United States
Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
SYNHSyneos Health | $4.46bn | 28.55 | n/a |
ALPNAlpine Immune Sciences | $4.46bn | n/a | n/a |
DNLIDenali Therapeutics | $4.41bn | n/a | n/a |
IMVTImmunovant | $4.34bn | n/a | n/a |
CRNXCrinetics Pharmaceuticals | $4.31bn | n/a | n/a |
CRSPCrispr Therapeutics AG | $4.17bn | n/a | n/a |
ACLXArcellx | $4.13bn | n/a | n/a |
MRTXMirati Therapeutics | $4.12bn | n/a | n/a |
ALKSVAlkermes | $4.05bn | 18.02 | n/a |
RYZBRayzebio | $3.81bn | n/a | n/a |
CBAYCymaBay Therapeutics | $3.73bn | n/a | n/a |
TGTXTG Therapeutics | $3.67bn | 39.54 | n/a |
BHVNBiohaven | $3.60bn | n/a | n/a |
DNAGinkgo Bioworks Holdings | $3.43bn | n/a | n/a |
MRUSMerus NV | $3.42bn | n/a | n/a |
DYNDyne Therapeutics | $3.42bn | n/a | n/a |
FOLDAmicus Therapeutics | $3.35bn | n/a | n/a |
GHGuardant Health | $3.30bn | n/a | n/a |
MLTXMoonLake Immunotherapeutics | $3.27bn | n/a | n/a |
ALVOAlvotech SA | $3.26bn | n/a | n/a |